CMS Open Payments · Program Year 2024
Rochester Medical Corporation
Rochester Medical Corporation reported $54.76 across General Payments, Research, and Ownership to 2 physicians and teaching hospitals across 2 transactions.
- $54.76 Below-median payer
- All-tracks total
- 2 Below-median volume
- Transactions
- 2 Below-median reach
- Recipients
- #1916
- of 1,925 companies
Rochester Medical Corporation reported $54.76 across all CMS Open Payments tracks (General + Research + Ownership) to 2 physicians and teaching hospitals in Program Year 2024 - ranking #1916 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $54.76, averaging $27.38 per recipient.
Rochester Medical Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer rochester-medical-corporation Rochester Medical Corporation
$54.76 · #1916/1,925 · 0.0% industry · PY2024
- TOT $54.76
- RANK #1916
- SHARE 0.0%
- TXN 2
- RCP 2
- CAT 1
- GEN $54.76
- TOP1 50.0%
- PY 2024
Volume peers
Nearest volume peer: STORZ MEDICAL America, Inc. ($55.30)
Rochester Medical Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Rochester Medical Corporation
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Rochester Medical Corporation that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $54.76, accounting for 100.0% of this company's General Payments and 2 transactions.
General Payment Breakdown by Type
Across 1 types of general payments, Rochester Medical Corporation's largest category was "Food and Beverage" at $54.76 - 100.0% of General Payments.
How Rochester Medical Corporation divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $54.76 | 2 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $54.76 (100.0%) of $54.76 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Rochester Medical Corporation
The five named recipients with the highest reported General Payments from this company
- 1
David Elkins
$27.38 across 1 reported transactions
- 2
John Mhoon
$27.38 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Rochester Medical Corporation ranks #1916 of 1,925 by total payments (bottom 1% by spend) but is notably more concentrated than that alone would suggest -- #370 of 1,838 by HHI (top 20% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Mighty Oak Medical : $7.2K total payments, HHI 5008
- Ferring SA de CV : $18.0K total payments, HHI 5003
- Cutting Edge Spine, LLC : $13.3K total payments, HHI 5002
- Episurf Medical, Inc. : $15.1K total payments, HHI 5002
- Luminex Corporation : $2.3K total payments, HHI 5001
- Dentsply Sirona KK : $32.4K total payments, HHI 5000
- Rochester Medical Corporation (this company) : $54.76 total payments, HHI 5000
- Astellas Pharma Europe BV : $143.10 total payments, HHI 5000
- Mobius Therapeutics, LLC : $1.0K total payments, HHI 5000
- SmartPractice Allergen Bank, L.L.C. : $1.4M total payments, HHI 5000
- LumiraDx, Inc. : $600.00 total payments, HHI 5000
- STORZ MEDICAL America, Inc. : $55.30 total payments, HHI 5000
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Rochester Medical Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Rochester Medical Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Rochester Medical Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Konan Medical USA, Inc.
Grifols Diagnostic Solutions, Inc.
RaySearch Laboratories AB (publ)
Sirona Dental, Inc.
DermaSensor Inc
Put this to use
Rochester Medical Corporation ranks #1916 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Rochester Medical Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.